MF
GBT

Manchester Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Manchester Financial’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$2K – 729
2021
Q1 		$2K Hold
40
– – ﹤0.01% 649
2020
Q4 		$2K Hold
40
– – ﹤0.01% 556
2020
Q3 		$2K Hold
40
– – ﹤0.01% 500
2020
Q2 		$3K Sell
40
-100
-71% -$6.86K ﹤0.01% 446
2020
Q1 		$7K Hold
140
– – 0.01% 322
2019
Q4 		$11K Buy
+140
New +$8.3K ﹤0.01% 348

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Manchester Financial's GBT Position: Q2 2021 in Review

Manchester Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 40 shares — an estimated $2K sold.

Manchester Financial first reported a position in GBT in Q4 2019 and held it in 6 quarters. The position peaked at $11K in Q4 2019. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • Manchester Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 40 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $2K.
  • Manchester Financial first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Global Blood Therapeutics, Inc. position peaked at $11K in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.